Logistics of participation in clinical trials
Scoles, L.; Silagy, C.
Australian Family Physician 22(3): 380-381
1993
ISSN/ISBN: 0300-8495 PMID: 8466447 Document Number: 414263
A decision to participate in a clinical drug trial will require a commitment in time and resources from both the doctor and other practice staff. The authors explain some of the strategies that can be used to maximise the limited time available for such research and minimise unnecessary wastage of scarce resources.
Document emailed within 1 workday
Related Documents
Weigmann, K. 2015: The ethics of global clinical trials: in developing countries, participation in clinical trials is sometimes the only way to access medical treatment. what should be done to avoid exploitation of disadvantaged populations? Embo Reports 16(5): 566-570Chen, X.; Zhu, X.N. 2014: Logistics Infrastructure Network Evaluation Method Research Based on Logistics Resource Integration in Railway Logistics Enterprises Advanced Materials Research 933: 941-946
Chen, X.; Zhu, X.N. 2014: Logistics Infrastructure Network Evaluation Method Research Based on Logistics Resource Integration in Railway Logistics Enterprises Advanced Materials Research 933: 941-946
Chen, X.; Zhu, X.N. 2014: Logistics Infrastructure Network Evaluation Method Research Based on Logistics Resource Integration in Railway Logistics Enterprises Advanced Materials Research 933: 941-946
Chen, X.; Zhu, X.N. 2014: Logistics Infrastructure Network Evaluation Method Research Based on Logistics Resource Integration in Railway Logistics Enterprises Advanced Materials Research 933: 941-946
Spaight, S.J.; Nash, S.; Finison, L.J.; Patterson, W.B. 1984: Medical oncologists' participation in cancer clinical trials Progress in Clinical and Biological Research 156: 49-61
Wilkie, R.; Jordan, J.L.; Muller, S.; Nicholls, E.; Healey, E.L.; van der Windt, D.A. 2011: Measures of social function and participation in musculoskeletal populations: Impact on Participation and Autonomy (IPA), Keele Assessment of Participation (KAP), Participation Measure for Post-Acute Care (PM-PAC), Participation Objective, Participation Subjective (POPS), Rating of Perceived Participation (ROPP), and the Participation Scale Arthritis Care and Research 63(Suppl 11): S325-S336
Wilkie, R.; Jordan, J.L.; Muller, S.; Nicholls, E.; Healey, E.L.; van der Windt, D.A. 2011: Measures of social function and participation in musculoskeletal populations: Impact on Participation and Autonomy (IPA), Keele Assessment of Participation (KAP), Participation Measure for Post-Acute Care (PM-PAC), Participation Objective, Participation Subjective (POPS), Rating of Perceived Participation (ROPP), and the Participation Scale Arthritis Care and Research 63(Suppl 11): S325-S336
Kennedy, B.M.; Burnett, M.F. 2007: Clinical research trials: factors that influence and hinder participation Journal of Cultural Diversity 14(3): 141-147
Crawley, L.M. 2001: African-American participation in clinical trials: situating trust and trustworthiness Journal of the National Medical Association 93(12 Suppl): 14S-17S
Copur, M.S. 2019: Inadequate Awareness of and Participation in Cancer Clinical Trials in the Community Oncology Setting Oncology 33(2): 54-57
Bullock, R.; Passmore, P.; Wilkinson, D.; Howard, R.; Jones, R. 2000: Effectiveness of rivastigmine in Alzheimer's disease. Participation in trials should be based on clinical uncertainty, not enforcement Bmj 320(7233): 511-512
Dhalla, S.; Poole, G. 2014: Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention Human Vaccines and Immunotherapeutics 10(7): 1974-1984
Namazu, K. 2007: Operational aspect of participation in the multi-national clinical trials from the foreign pharmaceutical company's standpoint Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(2): 328-330
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Ciaranello, A.L.; Walensky, R.P.; Sax, P.E.; Chang, Y.; Freedberg, K.A.; Weissman, J.S. 2009: Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents HIV Clinical Trials 10(1): 13-24
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Carol, C. Bienstock; Marla, B. Royne; Dan Sherrell; Thomas, F. Stafford 2008: An expanded model of logistics service quality: Incorporating logistics information technology International Journal of Production Economics 113(1): 205-222
Jiang, L.; Wang, Y.; Liu, D. 2014: Logistics cost sharing in supply chains involving a third-party logistics provider Central European Journal of Operations Research 24(1): 207-230
Keeffe, T.; Ormsby, G. 2015: A logistics support framework: a systems-based approach to logistics planning for development projects Development in Practice 25(6): 843-855